InvestorsHub Logo
Followers 7
Posts 289
Boards Moderated 0
Alias Born 12/11/2013

Re: olden_grumpini post# 360495

Thursday, 05/27/2021 8:14:52 AM

Thursday, May 27, 2021 8:14:52 AM

Post# of 402894
The research was very clear!

"The high CC50 (a measure of cytotoxicity) and low IC50 (a measure of potency) values observed for brilacidin in Calu-3 cells—yielding a Selectivity Index (SI) for brilacidin of 426 (CC50 = 241 µM/IC50 = 0.565 µM)—strongly support brilacidin’s treatment potential to achieve positive antiviral outcomes in humans. A vast majority of other drugs being evaluated as potential COVID-19 treatments, including repurposed drugs, have SIs that are much lower than that achieved by brilacidin"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News